OVERVIEW
FOCUS AREAS
Regulatory Affairs expert with 12+ years in CMC, specializing in global pharmaceutical submissions for Chemicals and Biologics.
CMC authoring and submissions
Developing regulatory strategies
Change control assessment and management
Regulatory intelligence
As CMC (Chemistry, Manufacturing and Controls) Manager of ELIQUENT Life Sciences, Constantina Kinni is working alongside a diverse array of clients on various projects covering pre- and post-approval submissions for Chemicals and Biologics. Her ability to manage intricate regulatory requirements underscores her commitment to the industry’s highest standards.
Constantina’s professional journey encompasses a 13-year tenure in Regulatory Affairs, with a particular focus on CMC; authoring quality sections submissions, developing and implementing regulatory CMC strategies, providing regulatory expertise on cross-functional project teams and managing complex project activities across multiple teams and departments. Her involvement in CMC projects equipped her with the ability to adeptly manage the intricate regulatory frameworks that govern this sector. Constantina’s capabilities are specifically tailored to meet the stringent requirements of the pharmaceutical regulatory field, positioning her as an important contributor to any team striving for excellence within this challenging industry.
-
EDUCATION:
Bachelor in Pharmacy Aristotle University of Thessaloniki
MSc in Toxicology University of SurreyCERTIFICATIONS:
Licensed Pharmacist with the Register of Pharmacists Pharmacy Board (Pharmaceutical Services, Ministry of Health Cyprus).
Completed numerous professional development courses in regulatory affairs, pharmacovigilance, and leadership. -
PROFESSIONAL EXPERIENCE:
Medochemie Ltd Regulatory Affairs Manager
Remedica Ltd Deputy Regulatory Affairs Manager and Head of CMCAREAS OF EXPERTISE:
Project Management
Regulatory Intelligence
Change Management
Problem solving
Leadership
Ready for Regulatory Clarity?
Stay informed as the regulatory landscape evolves.
Subscribe to our blog to receive the latest updates on policy changes, FDA developments, and their impact on the life sciences industry.